An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for ...
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, ...
New AI-driven systems for detecting and predicting gastrointestinal cancers have been developed through research projects in Singapore and South Korea. A research team from Singapore General Hospital ...
Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback